Sanofi received FDA Breakthrough Therapy designation for venglustat in type 3 Gaucher disease. The company also reported preclinical progress on an mRNA based in vivo CAR T cell therapy platform. Both ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers. Over the next few ...

SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health ...

Investors in Sunshine Biopharma are marking their calendars for a significant corporate event on March 31, 2026. The company is scheduled to release its latest financial results and provide ...

The impending departure of founders Ugur Sahin and Özlem Türeci by the end of 2026 has ushered BioNTech into a new strategic era. The market's initial reaction ...

We would also contend that it’s hard to predict such events a priori(10), and that more normal factor performance – which ...

All eyes are on Jerome Powell as he speaks live following the latest decision by the Federal Reserve to keep interest rates unchanged. While the pause was widely expected, markets are reacting in real ...

EnTRUST accelerator grants support commercialization by Puerto Rico teams. #NewsismyBusiness - Stay updated with the latest Puerto Rico business news, economy insights, finance, retail, tourism, and ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, PA / ACCESS ...

The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDTCompany ParticipantsSteven Harr - President, CEO ...

Welcome to the Citizens Life Science Conference Day 2. My name is Jon Wolleben, Senior analyst here. Pleased to have ProQR Therapeutics, a name we've covered for quite some time in many iterations, ...